An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Department of Genetic and Metabolic Diseases and Jacques Roboh, Department of Genetic Research, Hadassah Medical Center, Jerusalem 9112001, Israel; Faculty of Medicine, Hebrew University of Jerusalem, 9112001, Israel. Electronic address: annsr@hadassah.org.il.
1 Department of Genetic and Metabolic Diseases and Jacques Roboh, Department of Genetic Research, Hadassah Medical Center, Jerusalem 9112001, Israel; Faculty of Medicine, Hebrew University of Jerusalem, 9112001, Israel. Electronic address: annsr@hadassah.org.il.
Lopez-Gomez C, Hewan H, Sierra C, Akman HO, Sanchez-Quintero MJ, Juanola-Falgarona M, Tadesse S, Tanji K, Konofagou EE, Hirano M.Lopez-Gomez C, et al.EBioMedicine. 2019 Aug;46:356-367. doi: 10.1016/j.ebiom.2019.07.037. Epub 2019 Aug 2.EBioMedicine. 2019.PMID: 31383553Free PMC article.
References
Blázquez-Bermejo C., Molina-Granada D., Vila-Julià F., Jiménez-Heis D., Zhou X., Torres-Torronteras J. Age-related metabolic changes limit efficacy of deoxynucleoside based therapy in TK2-deficient mice. EBioMedicine. 2019
-
PMC
-
PubMed
Domínguez-González C., Madruga-Garrido M., Mavillard F., Garone C., Aguirre-Rodríguez F.J., Donati M.A. Deoxynucleoside therapy for thymidine kinase 2-deficient myopathy. Ann Neurol. 2019;86(2):293–303.
-
PMC
-
PubMed
Lopez-Gomez C., Hewan H., Sierra C., Akman H.O., Sanchez-Quintero M.J., Juanola-Falagarona M. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency. EBioMedicine. 2019
-
PMC
-
PubMed
Lopez-Gomez C., Levy R.J., Sanchez-Quintero M.J., Juanola-Falgarona M., Barca E., Garcia-Diaz B. Deoxycytidine and deoxythymidine treatment for thymidine kinase 2 deficiency. Ann Neurol. 2017;81(5):641–652.
-
PMC
-
PubMed
Moraes C.T., Shanske S., Tritschler H.J., Aprille J.R., Andreetta F., Bonilla E. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet. 1991;48(3):492–501.
-
PMC
-
PubMed